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Review article
Coronavirus disease-2019 (COVID-19), which started in 
Wuhan, China, in December 2019 and declared a worldwide 
pandemic on March 11, 2020, is a novel infectious disease 
that causes respiratory illness and death. Pediatric COVID-19 
accounts for a small percentage of patients and is often milder 
than that in adults; however, it can progress to severe disease 
in some cases. Even neonates can suffer from COVID-19, and 
children may spread the disease in the community. This review 
summarizes what is currently known about COVID-19 in 
children and adolescents.
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Introduction
In December 2019, a cluster of patients with pneumonia 
of unknown etiology were identified in Wuhan, China. A pre-
viously unknown betacoronavirus was detected in respiratory 
samples from the patients.1) The virus was named severe acute 
respiratory syndrome coronavirus 2 (SARS-CoV-2) and was 
deemed caused by coronavirus disease 2019 (COVID-19).2) 
COVID-19 rapidly swept mainland China and spread world-
wide, causing 118,319 confirmed cases and 4,292 deaths in 113 
nations as of March 11, 2020. The World Health Organization 
(WHO) declared COVID-19 a pandemic.3) In the Republic of 
Korea, starting with a Chinese traveler from Wuhan in January 
20,4) 7,755 confirmed cases leading to 60 deaths have occurred 
as of March 11, 2020.5)
COVID-19 is a novel infectious disease that is forecasted to 
have an enormous effect worldwide. This article reviews what 
is known about COVID-19 in children and adolescents as of 
March 12, 2020 in an effort to help clinicians managing pediatric 
cases.
Epidemiology in children
Published data on COVID-19 focuses primarily on adults, and 
the infection rate of COVID-19 in children is relatively low.6) 
The first pediatric case was reported on January 20, 2020, in a 
10-year-old boy from Shenzhen, China, whose family had visited 
Wuhan City.7) However, a retrospective study that enrolled 366 
children (≤16 years of age) hospitalized for respiratory infections 
between January 7 and 15, 2020 showed that COVID-19 was 
confirmed in 6 children (1.6%) whose onset of illness occurred 
between January 2 and 8, 2020. This study result suggests that 
SARS-CoV-2 infections in children were occurring early on in the 
epidemic.8)
Limited data are available on prevalence of COVID-19 in 
pediatric populations because children were rarely tested for the 
virus in earlier phase of the outbreak, especially in Hubei Province 
in China, where the most cases were confirmed.9) Until January 
31, 2020, of 11,791 confirmed COVID-19 cases in mainland 
China, 74 cases of pediatric patients (0.6%) aged 1.5 months to 
18 years were reported; 56% (34 of 61) of them had a history 
of household contact.10) Through February 7, 2020, although 
the data were incomplete, 285 pediatric cases of 34,546 (0.8%) 
confirmed patients were documented, and 71.2% (183 of 257) 
of infected children reported having household contact.11) The 
youngest affected patient was a 36-hour-old newborn, who 
remains the youngest COVID-19 patient worldwide.12) As of 
February 11, 2020, the Chinese Center for Disease Control and 
Prevention reported 44,672 laboratory-confirmed cases; 416 
cases (0.9%) were aged 0–9 years, and 549 (1.2%) were aged 
10–19 years; 1 death occurred in the 10–19 years age group, and 
fatality rate in this group was 0.18%.13) According to a report 
from the WHO-China Joint Mission on COVID-19, the largest-
scale report to date, 55,924 cases were laboratory-confirmed by 
February 20, 2020. The median patient age was 51 years (range, 
2 days to 100 years; interquartile range, 39–63 years); 2.4% of 
the affected patients were children under 19 years of age. Among 
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reported in these age groups. The COVID-19 incidence rate 
in Korea is calculated as 15.0 per 100,000 in all ages, 1.8 per 
100,000 in ages 0–9 years, and 8.2 per 100,000 in ages 10–19 
years according to national population data in February 2020 
(51,844,627 overall, 4,134,824 in the ages 0–9 years group, and 
4,920,794 in the ages 10–19 years group).5,26) As of March 11, 
2020, according to the pediatric age group analysis by school 
years performed by the Korea Centers for Disease Control and 
Prevention, 23 affected children were 0–2 years, 26 were 3–6 
years, 82 were 7–12 years, 78 were 13–15 years, and 123 were 
16–18 years (Fig. 1).27)
Clinical features in children
It is known that children with COVID-19 show milder 
symptoms than adults,11) but limited data exist on the burden 
of COVID-19 in children. A 10-year-old boy from Shenzhen, 
the first pediatric COVID-19 patient, was asymptomatic but 
displayed ground-glass opacity on an initial computed tomo-
graphy (CT) scan.7) Another study analyzed 10 laboratory-con-
firmed Chinese pediatric cases in Shanghai, Hainan, Hefei, and 
Quindao between January 19 and February 3, 2020; the median 
patient age was 74 months (range, 3–131 months). Fever was 
noted in 8, cough in 6, sore throat in 4, stuffy nose in 3, and 
rhinorrhea in 2 children. The fevers were 37.7°C–39.2°C and 
resolved within 24 hours. Patchy infiltrations were observed 
on the chest CT scans of 4 patients. None of the 10 patients 
children, 2.5% were severely ill and 0.2% were critical.6)
By February 10, 2020, a total of 10,924 adult cases and 398 
pediatric cases were confirmed in mainland China, excluding 
the Hubei Province. The rate of pediatric cases was 3.5% (398 
of 11,322).9) In 6 northern Chinese provinces, 31 children were 
diagnosed with COVID-19 between January 15 and February 
21, 2020. The median pediatric patient age was 7.1 years (range, 
6 months to 17 years); 21 children (68%) had a history of contact 
with a confirmed adult patient, while 28 children (90%) had an 
infected family member.14)
Pediatric COVID-19 cases outside of China have been spora-
dically reported, but limited data are available. Two Malaysian 
boys aged 2 years and 11 years on January 25,15) a German boy 
on January 31,16) a Singaporean 6-month-old boy on February 
5,17,18) and a Vietnamese 3-month-old infant on February 1119) 
were reported. All of these cases involved exposure to an infected 
family member.
In Singapore, after an index case from China was first diagnos-
ed with COVID-19 on January 23, 2020, the infection spread 
through community transmission. By March 11, 2020, 167 
patients were confirmed to have COVID-19, 6 (3.6%) of whom 
were children who were 6 months, 1 year, 2 years, 5 years, 12 
years, and 17 years of age. Three children were residents of 
Wuhan; 2 children had an infected family member, and 1 report-
ed exposure to an adult patient.17) In Italy, in which a rapid 
increase in confirmed COVID-19 cases ensued after the cluster 
cases on February 21, 2020, a total of 8,342 cases had been 
reported by March 9, 2020; 1.4% of cases were in children aged 
0–18 years, among whom there were no fatalities.20) In Australia, 
a total of 71 COVID-19 cases were confirmed by March 7, 
2020; 2 cases were diagnosed in the 0–9 years age group and 2 
in the 10–19 years age group; therefore, 5.6% of the confirmed 
cases were in the 0–19 years age group21) (Table 1).
In Korea, a 10-year-old girl whose mother and uncle had been 
diagnosed with COVID-19 was the first pediatric case, reported 
on February 18, 2020.22) Thereafter, newspapers reported a 
4-year-old on February 23,23) a 45-day-old infant on February 
29,24) and a 4-week-old newborn on March 8.25) The 4-year-
old was in contact with an infected daycare teacher, while the 
45-day-old and the 4-week-old each were in contact with an 
infected family member.
As of midnight March 11, 2020, a total of 7,755 patients had 
confirmed disease, of whom 75 (1.0%) were aged 0–9 years 
and 405 (5.2%) were aged 10–19 years. No fatalities have been 
Table 1. Summary of epidemiology studies of pediatric cases of coronavirus disease 2019
Variable
Study area
China10) China11) China13) China6) Singapore17) Italy20) Australia21) Republic of Korea5)
Study period ~ 31 Jan, 2020 ~ 7 Feb, 2020 ~ 11 Feb, 2020 ~ 20 Feb, 2020 ~ 11 Mar, 2020 ~ 9 Mar, 2020 ~ 7 Mar, 2020 ~ 11 Mar, 2020
Total confirmed 
patients
11,791 34,546 44,672 55,924 167 8,342 71 7,755
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Fig. 1. Cumulative numbers of pediatric diagnoses of coronavirus disease 
2019 in Korea by age group.
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required oxygen therapy.28) Another study described 9 infants 
(age range, 1–11 months) in China outside of Hubei Province. 
Among the 7 infants who reported symptoms, 4 had fever, 2 had 
mild respiratory symptoms, and 1 was asymptomatic; no severe 
complications were noted.29)
In a study that enrolled 31 pediatric patients from 6 northern 
Chinese provinces between January 25 and February 21, 2020, 
4 cases (12.9%) were asymptomatic, 13 (41.9%) were mildly 
symptomatic with normal radiography findings, 14 (45.2%) had 
pneumonia, and none had severe illness. Ten of the 31 patients 
(32.3%) complained of fever over 38°C, and 10 (32.3%) had 
a mild fever of 37.3°C–38°C. The fever lasted 1–9 days and 
subsided within 3 days in 15 patients (75%). Fourteen (45.2%) 
had a dry cough, 3 experienced fatigue, 3 had headache or 
dizziness, 2 had rhinorrhea, and 2 had a sore throat. One of 
the patients reported having a sore throat only, and 3 patients 
initially presented with diarrhea but without vomiting.14)
To date, 2 studies have described chest CT findings of pe-
diatric patients in detail.30,31) One study analyzed 15 pediatric 
COVID-19 cases admitted to a hospital in Shenzhen, China, 
between January 16 and February 6, 2020. The median patient 
age was 7 years (range, 4–14 years). At the time of diagnosis, 5 
patients complained of fever, 1 had a cough, 1 had nasal conges-
tion, and 8 (53.3%) were asymptomatic. The leukocyte count 
was decreased in 8 (53.3%) and within the normal range in 7 
children. At the time of diagnosis, the chest CT scan revealed 
ground-glass opacity in 9 (60%) and appeared normal in 6 pati-
ents. A follow-up CT performed after 3–5 days showed the 
development of new inflammatory lesions with ground-glass 
opacity in 3 of 9 patients whose SARS-CoV-2 polymerase chain 
reaction (PCR) results continued to be positive. Among the 6 
patients whose PCR results became negative, the follow-up chest 
CT findings improved in 2.30)
A study reported 20 pediatric COVID-19 patients admitted 
to the Wuhan Children’s Hospital in China between January 
23 and February 8, 2020. The median patient age was 2.1 years 
(range, 1 day to 14.6 years), and 3 neonates were included in 
the study. Thirteen patients complained of cough, 12 had a 
fever over 37.3°C, 3 had diarrhea, 3 had rhinorrhea, and 2 had 
tachypnea. Respiratory crackles were auscultated in 3 patients, 
chest retraction was observed in 1, and cyanosis was observed 
in 1. Most patients presented with signs of pneumonia. The 
leukocyte count was within the normal range in 14 (70%), de-
creased in 4 (20%), and increased in 2 patients (10%). The 
percentage of lymphocytes was decreased in 7 (35%) and in-
creased in 3 patients (15%). C-reactive protein was increased in 
9 (45%), and procalcitonin was increased in 16 patients (80%). 
Eight patients (40%) were coinfected with influenza A or B 
virus, Mycoplasma pneumoniae, respiratory syncytial virus, or 
cytomegalovirus. The initial chest CT scan showed unilateral 
pulmonary lesions in 6 (30%), bilateral pulmonary lesions in 10 
(50%), and no abnor mality in 3 neonates and 1 child (4 of 20, 
20%). All 20 child ren displayed subpleural lesions with localized 
inflammatory infiltra tion, 10 (50%) showed consolidation with 
surrounding halo sign, 12 (60%) showed ground-glass opacity, 
4 (20%) showed a fine mesh shadow, and 3 (15%) showed tiny 
nodules.31)
The first severe pediatric case reported was a 13-month-old 
boy admitted to Wuhan Children’s Hospital on January 27, 
2020. He presented with pneumonia, shock, acute respiratory 
distress, and renal failure at the time of admission. The patient 
had no known medical comorbidities; he had reportedly been 
treated at a local clinic for the past 6 days for intermittent diarr-
hea and vomiting but had no respiratory symptoms. He showed 
fever, dyspnea, and oliguria at the time of admission and received 
intensive care including intubation and mechanical ventilation. 
After treatment, he recovered gradually.32)
The largest-scale report to date on COVID-19 in children 
examin ed 134 patients whose clinical data were available among 
285 pediatric cases diagnosed in China as of February 7, 2020. 
The most common symptoms were fever and cough; other cli-
nical features included fatigue, myalgia, rhinorrhea, nasal con-
gestion, sore throat, headache, dizziness, nausea, vomiting, 
ab dominal pain, and diarrhea. The symptoms mostly resolved 
within a week. Among the 117 children whose body tempera-
tures were recorded, 89 (76.1%) had a fever that lasted usually 
1–2 days but up to 8 days. Complete blood counts were within 
the normal range in most patients; 2 showed a decreased leu-
kocyte count, while 1 showed a slight decrease in lymphocyte 
count. C-reactive protein was normal or temporarily increased 
(>20 mg/L in 3 patients). When the 134 cases were classified by 
symptoms and chest radiology findings, 9 patients (6.7%) were 
asymptomatic with normal chest radiology findings, 87 (64.9%) 
had mild symptoms with normal chest radiology findings, 36 
(26.9%, including 7 subclinical patients) had pneumonia, and 
2 (1.5%) were critically ill (both of whom were mechanically 
ventilated). One of the critically ill patients was moderately 
malnourished and had a history of cardiac surgery for treating 
a congenital heart disease, while the other had hydronephrosis 
and a left renal stone. Among 54 patients for whom chest radio-
logy data were available, 38 displayed ground-glass opacity or 
exudative/infiltrative lesions; of those, 7 were subclinical, 4 dis-
played increased pulmonary markings, and 12 showed no ab-
normalities.11)
In addition to the studies on clinical manifestations of COVID- 
19, one study analyzed pathogens retrieved from hospitalized 
children with respiratory infections during the early COVID-19 
outbreak in Wuhan, China. Among the 366 children (≤16 years 
of age) admitted to 3 hospitals in Wuhan between January 7 
and 15, 2020, 43 (11.7%) were infected with influenza A or B, 
while 6 (1.6%) were infected with SARS-CoV-2. Children with 
COVID-19 were aged 1–7 years. All 6 children had fever over 
39°C (duration, 3–11 days; median, 6 days) and cough, and 4 of 
them had vomiting. The chest CT scans showed pneumonia in 4 
patients. One patient, a 3-year-old in whom ground-glass opacity 
was noted on the chest CT scan, received intensive care including 
oxygen therapy. The median length of stay was 7.5 days (range, 
5–13 days), and all patients recovered.8)
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In summary, children with COVID-19 most commonly pre-
sent with fever, cough, and fatigue along with nasal stuffiness, 
rhinorrhea, sputum, diarrhea, and headache. Patients may be 
afebrile or present with a mild fever; fever subsides within 1–2 
weeks in most cases. Dyspnea and cyanosis can occur as the 
condition progresses, usually after 1 week of the disease and ac-
companied by systemic symptoms such as malaise or restless ness, 
poor feeding, poor appetite, and decreased activity. Pneumonia 
may develop; in some cases, it rapidly progresses and may cause 
respiratory failure that cannot be corrected by conventional 
oxygen therapy within 1–3 days. In severe cases, septic shock, 
metabolic acidosis, and irreversible bleeding and coagulation 
dysfunction might occur.33,34) Ground-glass opacity and subpleu-
ral lesions were commonly observed on the chest CT scans (Table 
2).30,31)
In Korea, a case report on the first COVID-19 pediatric pati-
ent is the only known academic publication in children to date. 
A 10-year-old girl presented with a mild fever (37.3°C) and 
scarce amount of sputum. She tested positive for SARS-CoV-2. 
On the 4th day after symptom onset, the chest CT scan showed 
patchy nodular consolidations accompanied by ground-glass 
opacity. She did not require antiviral therapy and recovered after 
supportive care.22)
Importance of managing children with COVID-19
Numerous family clustering cases of COVID-19 have been 
reported in China. Of 1,836 cases that occurred in Guangdong 
and Sichuan Provinces, 1,308 were related to 344 clusters, 
Table 2. Summary of studies on clinical manifestations of pediatric coronavirus disease 2019
Variable
Liu et al.8) 
(n=6)
Cai et al.28) 
(n=10)
Wei et al.29) 
(n=9)
Wang et al.14) 
(n=31)
Feng et al.30) 
(n=15)







Characteristics of the study 
and study area
Hospitalized child ren 
with acute respira tory 
infec tions in Wuhan, 
China



















Study period 7 Jan–15 Jan, 2020 19 Jan–3 Feb, 
2020
8 Dec 2019–6 Feb 
2020
25 Jan–21 Feb, 
2020
16 Jan–6 Feb, 
2020
23 Jan–8 Feb, 2020 ~7 Feb, 2020
Male sex 2 (33.3%) 4 (40.0%) 2 (22.2%) 15 (48.4%) 5 (33.3%) 13 (65.0%)
Age, median (range) 3 yr (1–7) 6.2 yr (0.3–10.9) 0.6 yr (0.2–0.9) 7.1 yr (0.5–17) 7 yr (4–14) 2.1 yr (1 day–14.6 yr) Youngest: 36 hr
Clinical classifications NA NA
Asymptomatic 0 (0.0%) 0 (0.0%) 4 (12.9%) 0 (0%) 9 (6.7%)
Acute upper respira tory 
tract infec tion
2 (33.3%) 6 (60.0%) 13 (41.9%) 3 (20.0%) 87 (64.9%)
Mild pneumonia 3 (50.0%) 4 (40.0%) 14 (45.2%) 12 (80.0%) 36 (26.9%)
Severe pneumonia 1 (16.7%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Critical case 0 (0%) 0 (0%) 0 (0%) 0 (0%) 2 (1.5%)
Clinical symptoms 7 Available 117 Available
Fever 6 (100%) 8 (80.0%) 4 (57.1%) 20 (64.5%) 5 (33.3%) 12 (60.0%) 89 (76.1%)
Cough 6 (100%) 6 (60.0%) 2 (28.6%) 14 (45.2%) 1 (6.7%) 13 (65.0%) NA
Rhinorrhea/sneezing 1 (16.7%) 2 (20.0%) 1 (14.3%) 2 (6.5%) NA 3 (15.0%) NA
Sore throat NA 4 (40.0%) NA 2 (6.5%) NA 1 (5.0%) NA
Headache/dizziness NA NA NA 3 (9.7%) NA NA NA
Diarrhea NA 0 (0.0%) NA 3 (9.7%) NA 3 (15.0%) NA
Dyspnea/tachypnea 1 (16.7%) 0 (0.0%) NA 0 (0.0%) NA 2 (10.0%) NA
Laboratory findings NA NA NA







3 (10.0%, 3/30) 7 (35.0%) (>3 mg/L)
Abnormal liver enzymes 4 (66.7%) 2 (10.0%) 
(AST>40 U/L)




5 Available NA NA 30 Available 54 Available
Normal 1 (20.0%) 16 (53.3%) 6 (40.0%) 4 (20.0%) 12 (22.2%)
Abnormal 4 (80.0%): 3 patchy 
shadows in both 
lungs, 1 patchy 
ground-glass 
opacities in both lungs




9 (60.0%): 9 
ground-glass 
opacities
16 (80.0%): 10 
consolidation with 
surrounding halo sign, 
12 ground-glass 
opacities, 4 fine mesh 
shadow, 3 tiny nodules
42 (77.8%): 38 
ground-glass or 
exudative/invasive 
lesions, 4 increased 
pulmonary 
markings
ALT, alanine transaminase; AST, aspartate transaminase; NA, not available.
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most (78%–85%) of which occurred in families. According to a 
preliminary study ongoing in Guangdong, China, the secondary 
attack rate within a household is estimated to be 3%–10%.6) 
Children primarily contract the disease through household ex-
posure, and 56%–90% of infected children had an infected 
family member.10,11,14,28)
Children are usually diagnosed with COVID-19 after an ex-
posure to an infected adult within or outside of the family circle; 
however, the source of infection could not be identified in some 
cases, while the diagnosis of a child preceded that of an adult 
in others. A 3-month-old child with confirmed COVID-19 on 
January 26, 2020, in Hubei Province was hospitalized with fever 
and found to have mild pneumonia on the chest CT scan. At the 
time of diagnosis, his parents were asymptomatic with negative 
SARS-CoV-2 PCR results. After 7 days of hospitalization of 
the infant, his father complained of fever and fatigue, while his 
mother was asymptomatic; both of his parents showed signs of 
pneumonia on the chest CT scan and had positive SARS-CoV-2 
PCR results. It was undetermined whether the incubation period 
was shorter in the infant than in the parents or the virus was 
transmitted from the infant to the parents.9,35) In the first severe 
case of a 13-month-old who developed pneumonia, shock, acute 
respiratory distress, and renal failure, the source of infection 
could not be identified. His parents were not tested for SARS-
CoV-2.32)
Influenza surveillance during the first 2 weeks of January 2020 
in Wuhan City, in which the COVID-19 outbreak originated, 
indicated that SARS-CoV-2 was detected in adults but not in 
children.6) In an analysis of 365 COVID-19 cases confirmed till 
February 5, 2020, in Shenzhen, China, the pediatric infection 
rate rapidly increased from 2% (before January 24) to 13% 
(between January 25 and February 5) (P<0.001). The possible 
reasons for this might be that exposure to SARS-CoV-2 was 
lower in children in the early course of the outbreak. Otherwise, 
children were less likely to be tested because of their mild pre-
senting symptoms and signs, especially in the setting of limited 
resources in the early phase of the outbreak.36)
Little is known about the duration of viral shedding in 
children, and the reported durations varied widely across pati-
ents and samples. A 6-month-old infant diagnosed in Singapore 
on February 4, 2020 was asymptomatic but tested positive for 
SARS-CoV-2 PCR on a nasopharyngeal sample; his mother 
previously had confirmed COVID-19 pneumonia. The blood 
PCR sample turned positive for SARS-CoV-2 on hospital day 2, 
when the patient had a fever of 38.5°C that resolved immediately. 
A series of daily nasopharyngeal samples for PCR revealed that 
viral load presented as a 1/cycle threshold that peaked at the time 
of diagnosis and decreased over time. Negative conversion was 
achieved on hospital day 17. Stool PCR on hospital day 2 was 
negative but turned positive on day 9.18)
In a study that enrolled 10 Chinese children in Shanghai, 
Hainan, Hefei, and Qingdao, symptoms appeared at a median 
6.5 days (range, 2–10 days) from the onset of illness in the 
index case. Patients tested positive for SARS-CoV-2 PCR on a 
nasopharyngeal or throat swab 4–48 hours after symptom onset, 
while negative conversion was seen at a median 12 days (range, 
6–22 days). Prolonged shedding of viral RNA in the feces was 
observed for 18–30 days in 5 patients.28)
In summary, the transmission of SARS-CoV-2 in children 
primarily occurs through contact with adult patients, mainly 
through household exposure. In contrast, direct transmission 
from a child to an adult has not been reported to date. However, 
the observation of prolonged detection of viral RNA in naso-
pharyngeal/throat swabs and feces of pediatric patients suggests 
that children and adolescents may be transmitters in the com-
munity.
Considerations in pregnant women and 
newborns
In the report of the WHO-China Joint Mission on COVID-19 
patients diagnosed through February 20, 2020, pregnant women 
were not at higher risk for severe COVID-19. Of 147 (64 
confirmed, 82 suspected, and 1 asymptomatic) preg nant women 
investigated, 8% had severe signs consisting of dyspnea and 
hypoxemia, while 1% was critical and requir ed intensive care.6) 
However, pneumonia is one of the most common infections 
during pregnancy, as it may lead to pre mature rupture of the 
membranes, preterm labor, intrauterine growth retardation, and 
stillbirth.37-39) Sporadic case reports on COVID-19 in pregnant 
women observed obstetric complications including stillbirth, 
preterm birth, and premature rupture of the membranes.40-43) 
In a study of 9 pregnant women with COVID-19 diagnosed in 
Wuhan, China, from January 20 to 31, 2020, all women were 
infected at gestational age 36 weeks or later and delivered by 
caesarean section. Seven women complained of fever at the time 
of diagnosis, but none developed severe pneumonia that led 
to mechanical ventilation or death. Obstetrical complications 
included preterm deliveries in 4 and premature rupture of the 
membranes in 2; no cases of neonatal asphyxia or stillbirth were 
observed. From 6 patients, amniotic fluid, cord blood, breast 
milk, and neonatal throat swab samples were tested for SARS-
CoV-2; all were negative.40) A case report from Suzhou, China, 
described a pregnant woman at 30-week gestation. She was 
diagnosed with COVID-19 pneumonia on February 6, 2020 
and delivered a 1.83-kg preterm baby via emergency caesarean 
section due to fetal distress. SARS-CoV-2 PCR of the amniotic 
fluid, placenta, cord blood, neonatal gastric juice, and neonatal 
throat swab was negative.41) A study analyz ing 13 pregnant 
women with COVID-19 from December 8, 2019 to February 
25, 2020 in mainland China outside of Wuhan included 2 
women in their second trimester. Ten women had fever, 3 had 
dyspnea, and 1 was asymptomatic. Of the 13 women, 3 (23%) 
recovered and were discharged with uncom plicated ongoing 
pregnancy; 10 delivered by caesarean section. Five women 
underwent emergency caesarean section due to fetal distress (3 
cases), premature rupture of membrane (1 case), and stillbirth (1 
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case). Six women had preterm labor. At 34-week gestation, one 
of the women developed acute respiratory distress syndrome 
and multiple organ failure requiring extra corporeal membrane 
oxygenation support; her baby was still birth.42)
In a report of 10 neonates born to 9 mothers with COVID-19 
in Hubei, China, between January 20 and February 5, 2020, 
intrauterine distress was observed in 6 and premature rupture 
of the membranes was observed in 3. Six infants were born 
pre mature, 2 were small for gestational age, and 1 was large 
for gestational age. Clinical features of the newborns included 
shortness of breath (6 cases) and fever (2 cases). Two newborns 
developed thrombocytopenia complicated by abnormal liver 
function. One of the newborns was delivered at 34 weeks and 
5 days’ gestation, developed shock and multiple organ failure 
on day 8, and died on day 9. Nine of the newborns underwent 
SARS-CoV-2 PCR testing on days 1–9; all were negative.44) To 
date, there have been no reports of the vertical transmission of 
SARS-CoV-2. However, existing reports are incomplete because 
they included small sample sizes, primarily dealt with COVID-19 
occurring in the third trimester, and not all pregnant women 
underwent SARS-CoV-2 PCR testing. Continuous monitoring is 
needed to assess the possibility of mother-to-child transmission.
To date, 3 cases of confirmed COVID-19 in neonates have 
been reported in Wuhan, China.11,12,31,45) A neonate was dia-
gnosed with COVID-19 at 36 hours after birth. His mother 
was at 40 weeks' gestation and developed a fever on February 1, 
2020. The chest CT scan displayed ground-glass opacities sug-
gestive of viral pneumonia. An emergency caesarean section was 
performed the same day and the newborn did not have contact 
with the mother after birth. The mother’s SARS-CoV-2 PCR 
result was positive the next day. A pharyngeal swab collected 
from the newborn at 36 hours after birth later tested positive 
for SARS-CoV-2. However, the cord blood, placenta, and 
breast milk were negative for SARS-CoV-2. The newborn was 
afebrile with no coughing or vomiting; however, the chest CT 
scan showed a nodular shadow under the pleura on day 6. The 
follow-up chest CT scan showed small patchy shadows on day 
12 that improved on day 17. SARS-CoV-2 PCR conducted of 
pharyngeal and anal swabs on day 17 were negative and he was 
discharged on day 18.12) Another 5-day-old neonate with a fever 
was diagnosed with COVID-19, and his mother was diagnosed 
with COVID-19.11) A 17-day-old newborn was hospitalized 
on February 5, 2020 with a 1-week history of sneezing and 
vomiting. His parents were diagnosed with COVID-19 3 days 
prior. His chest CT scan showed increased pulmonary markings; 
all symp toms resolved by hospitalization day 7.45) A small 
number of neonatal COVID-19 have been reported to date, 
and the infected neonates had mild or no symptoms. However, 
current data support that neonates are susceptible to COVID-19; 
therefore, special precautions including hand hygiene are re-
quired of individuals in close contact with newborns (Table 3).
Conclusion
COVID-19 is a novel infectious disease that was recently 
declared a pandemic. It is rapidly spreading worldwide, infecting 
and killing thousands of people. Limited information is available 
on this previously unknown coronavirus that has been around 
for less than 3 months. It is known that children comprise a 
small fraction of COVID-19 cases, and their symptoms are often 
mild. However, some pediatric cases may progress to severe 
disease, and initial atypical presentations may delay the diagnosis 
of COVID-19, leading to unfavorable outcomes. It is worth 
Table 3. Summary of studies on perinatal cases of coronavirus disease 2019
Variable Chen et al.40) Liu et al.42) Zhu et al.44)
Study area Wuhan, China Outside Wuhan, China Hubei Province, China
No. of pregnant women cases (laboratory-confirmed 
SARS-CoV-2)
9 13 9
No. of births 9 10 10
Study period 20 Jan–31 Jan, 2020 8 Dec 2019–25 Feb, 2020 20 Jan–5 Feb, 2020
Maternal age (yr), median (range) 28 (26–40) 30 (22–36) 30 (25–35)
Gestational age (wk), median (range) 37 wk 2 days (36 wk–39 wk 4 days) 35 wk (25 wk–38 wk 3 days) 34 wk 6 days (31–39 wk)
Maternal severe pneumonia 0 (0%) 1a) (7.7%) NA
Discharge without complication before delivery 0 (0%) 3 (23.1%) 0 (0%)
Delivery-related information
Caesarean section 9 (100%) 10 (100%) 7 (77.8%)
Preterm labor/delivery 4 (44.4%) 6 (60.0%) 6 (66.7%)
Fetal distress 2 (22.2%) 3 (30.0%) 6 (66.7%)
Premature rupture of the membranes 2 (22.2%) 1 (10.0%) 3 (33.3%)
Stillbirth 0 (0%) 1a) (10.0%) 0 (0%)
Neonatal asphyxia 0 (0%) 0 (0%) 0 (0%)
Postnatal death 0 (0%) 0 (0%) 1b) (10.0%)
NA, not available; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
a)The mother’s condition deteriorated during hospitalization, requiring mechanical ventilation with extracorporeal membrane oxygenation support. 
b)The neonate died of refractory shock and gastric bleeding. 
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mentioning that newborns are susceptible to this disease and 
viruses are detected for a prolonged period; therefore, newborns 
might play a role in community transmission. There is currently 
no standard of management or prevention. Further investigation 
is needed to assess the reason for differences in clinical features of 
COVID-19 by age, evaluate the role of children in community 
transmission, and develop treatment and vaccines for the 
disease. We hope that current and future research on COVID-19 
can answer these questions and look forward to wisely managing 
this crisis for mankind.
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